Kidney Injury Molecule-1 Correlates With Kidney Function in Heart Allograft Recipients

被引:6
|
作者
Przybylowski, P. [1 ]
Malyszko, J. [2 ]
Kozlowska, S. [1 ]
Malyszko, J. S. [2 ]
机构
[1] Jagiellonian Univ, Dept Cardiovasc Surg & Transplantatol, John Paul II Hosp, Coll Med, PL-31202 Krakow, Poland
[2] Med Univ, Dept Nephrol & Transplantol, Bialystok, Poland
关键词
TRANSPLANT RECIPIENTS; KIM-1; BIOMARKER; DISEASE; DYSFUNCTION; CELLS;
D O I
10.1016/j.transproceed.2011.08.049
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serum creatinine and estimated glomerular filtration rate (eGFR) (24 hours creatinine clearance, Modification of Diet in Renal Disease, Chronic Kidney Disease Epidemiology Collaboration, Cockcroft-Gault formulae), and urinary kidney injury molecule-1 (KIM-1), were evaluated in 111 heart allograft recipients on therapy with a calcineurin inhibitor, mycophenolate mofetil or azathioprine plus prednisone. KIM-1 was assessed using commercially available assay. Normotensive heart allograft recipients showed significantly lower KIM-1 values than hypertensive subjects. Urinary KIM-1 was significantly higher among New York Heart Association class III versus I and II patients. Upon univariate analysis, urinary KIM-1 strongly correlated with serum creatinine (r = .54) and eGFR (r = .66) but only weakly with other parameters. It was not related to cystatin C. Upon multiple regression analysis, the best predictor of urinary KIM-1 was eGFR (beta -0.56), explaining 76% of KIM-1 concentrations. Even a successful heart transplantation is associated with kidney injury as reflected by elevated urinary KIM-1 and reduced eGFR. Therefore, KIM-1 needs to be investigated as a potential early marker for impaired kidney function/kidney injury, especially in patients with other risk factor for kidney damage, for example, hypertension or congestive heart failure.
引用
收藏
页码:3061 / 3063
页数:3
相关论文
共 50 条
  • [21] Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease
    Gohda, Tomohito
    Kamei, Nozomu
    Koshida, Takeo
    Kubota, Mitsunobu
    Tanaka, Kanako
    Yamashita, Yoshinori
    Adachi, Eri
    Ichikawa, Saki
    Murakoshi, Maki
    Ueda, Seiji
    Suzuki, Yusuke
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (02) : 435 - 440
  • [22] Kidney Injury Molecule-1 and the Loss of Kidney Function in Diabetic Nephropathy: A Likely Causal Link in Patients With Type 1 Diabetes
    Panduru, Nicolae M.
    Sandholm, Niina
    Forsblom, Carol
    Saraheimo, Markku
    Dahlstrom, Emma H.
    Thorn, Lena M.
    Gordin, Daniel
    Tolonen, Nina
    Waden, Johan
    Harjutsalo, Valma
    Bierhaus, Angelika
    Humpert, Per M.
    Groop, Per-Henrik
    DIABETES CARE, 2015, 38 (06) : 1130 - 1137
  • [23] Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years
    Schulz, Christina-Alexandra
    Engstrom, Gunnar
    Nilsson, Jan
    Almgren, Peter
    Petkovic, Marinka
    Christensson, Anders
    Nilsson, Peter M.
    Melander, Olle
    Orho-Melander, Marju
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (02) : 265 - 273
  • [24] Association between the levels of urine kidney injury molecule-1 and the progression of acute kidney injury in the elderly
    Xie, Yuanyuan
    Wang, Qin
    Wang, Chunlin
    Che, Xiajing
    Shao, Xinghua
    Xu, Yao
    Ni, Zhaohui
    Mou, Shan
    PLOS ONE, 2017, 12 (02):
  • [25] Evaluation of the Urinary Kidney Injury Molecule-1 Levels in Patients With Diabetic Nephropathy
    Tekce, Buket Kin
    Tekce, Hikmet
    Aktas, Gulali
    Sit, Mustafa
    CLINICAL AND INVESTIGATIVE MEDICINE, 2014, 37 (06): : E377 - E383
  • [26] Does the kidney injury molecule-1 predict cisplatin-induced kidney injury in early stage?
    Tekce, Buket Kin
    Uyeturk, Ummugul
    Tekce, Hikmet
    Uyeturk, Ugur
    Aktas, Gulali
    Akkaya, Akcan
    ANNALS OF CLINICAL BIOCHEMISTRY, 2015, 52 (01) : 88 - 94
  • [27] Relationships of kidney injury molecule-1 with renal function and cardiovascular risk factors in the general population
    Egli, Peter
    Aeschbacher, Stefanie
    Bossard, Matthias
    Eggimann, Lucien
    Blum, Steffen
    Meyre, Pascal
    Bargetzi, Laura
    Estis, Joel
    Todd, John
    Risch, Martin
    Risch, Lorenz
    Conen, David
    CLINICA CHIMICA ACTA, 2018, 478 : 13 - 17
  • [28] Kidney Injury Molecule-1 is Elevated in Nephropathy and Mediates Macrophage Activation via the Mapk Signalling Pathway
    Tian, Lei
    Shao, Xinghua
    Xie, Yuanyuan
    Wang, Qin
    Che, Xiajing
    Zhang, Minfang
    Xu, Weijia
    Xu, Yao
    Ni, Zhaohui
    Mou, Shan
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (02) : 769 - 783
  • [29] Kidney injury molecule-1 and urinary gamma-glutamyl transferase as biomarkers of acute kidney injury in cats
    Xavier Junior, F. A. F.
    Morais, G. B.
    Silveira, J. A. M.
    Sampaio, T. L.
    Martins, A. M. C.
    Silva, I. N. G.
    Viana, D. A.
    Evangelista, J. S. A. M.
    JOURNAL OF SMALL ANIMAL PRACTICE, 2022, 63 (03) : 203 - 210
  • [30] Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy
    Seo, Mi Seon
    Park, Moo Yong
    Choi, Soo Jeong
    Jeon, Jin Seok
    Noh, Hyunjin
    Kim, Jin Kuk
    Han, Dong Cheol
    Hwang, Seung Duk
    Jin, So Young
    Kwon, Soon Hyo
    BMC NEPHROLOGY, 2013, 14